Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 7 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Cyclophosphamide 2064 Radiotherapy 1984 Cisplatin 1851 Carboplatin 1557 Gemcitabine 1452 Paclitaxel 1320 Bevacizumab 1316 pembrolizumab 1235 Docetaxel 1225 Oxaliplatin 1181 Capecitabine 1173 Fluorouracil 1081 Dexamethasone 979 Magnetic Resonance Spectroscopy 967 Nivolumab 936 Rituximab 928 Drug Therapy 911 Surveys and Questionnaires 898 Doxorubicin 845 Etoposide 843 Radiosurgery 814 Blood Specimen Collection 814 Irinotecan 783 Cytarabine 743 fludarabine 723 Leucovorin 682 Surgical Procedures, Operative 638 Lenalidomide 618 Biopsy 592 fludarabine phosphate 568

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × zilucoplan × Clear all

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations

Ohio State University

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡